Bruxism Treatment Market, By Product Type (Mouth Guards, NTI-TSS and Splints), By Patient Type (Adult and Pediatric), By End User (Hospitals, Dental Clinics, Homecare Settings and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jan 2023

Code : CMI5197

Pages :190

Formats :

Excel and PDF

Industry : Pharmaceutical

Market News

Global Bruxism Treatment Market: Key Developments

On October 7, 2022, Desktop Health, a healthcare business within Desktop Metal, Inc., a company focused on developing 3D printing solutions for personalized medicine, announced that it had received the U.S. Food and Drug Administration (FDA) 510(k) clearance of SmileGuard resin, a light, biocompatible material for the fabrication of strong & flexible bite splints and other orthodontic and dental appliances.

On November 17, 2022, RespireRx Pharmaceuticals Inc., a pharmaceutical company, announced that on November 14, 2022, the company entered into a letter of intent (LOI) with an Australia headquartered, bespoke clinical research organization focused on cannabinoid and psychedelic clinical research. Under the contract, the CRO (clinical research organization) is expected to provide full service CRO services, including regulatory, compliance, and GMP (good manufacturing practices) manufacturing services in addition to human pharmacokinetic and pivotal human efficacy and safety studies of dronabinol for the treatment of obstructive sleep apnea.

On June 23, 2022, Yenepoya (Deemed to be University), Karnataka, India and DentCare Dental Lab Pvt. Ltd, Muvattupuzha, in Kerala, India signed a memorandum of understanding (MoU). Yenepoya is taking a major step towards providing an opportunity to aspiring candidates intending to make a career in dental technology.